PubRank

Sasan Roayaie

Author PubWeight™ 94.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008 9.20
2 Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2008 5.93
3 The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg 2009 5.33
4 Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008 4.35
5 Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 2008 4.03
6 Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007 3.85
7 Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011 2.66
8 Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol 2009 2.42
9 Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013 2.42
10 Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol 2011 2.39
11 A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006 2.32
12 Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol 2008 2.22
13 Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007 1.95
14 MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology 2011 1.77
15 Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg 2012 1.70
16 Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 2015 1.53
17 Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 2011 1.46
18 De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci 2006 1.45
19 Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004 1.36
20 Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on "Surgical Misinterpretation" of the BCLC Staging System. Ann Surg 2015 1.17
21 Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant 2004 1.17
22 Feasibility and preliminary accuracy of high-resolution imaging of the liver and pancreas using FNA compatible microendoscopy (with video). Gastrointest Endosc 2012 1.09
23 Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 2007 1.07
24 Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg 2002 1.03
25 Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl 2009 1.02
26 Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg 2008 1.02
27 Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg 2014 0.99
28 How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol 2005 0.97
29 Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 2004 0.93
30 Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis 2011 0.91
31 Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor? Liver Transpl 2005 0.90
32 Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis. Semin Liver Dis 2008 0.88
33 Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review. Pediatr Transplant 2015 0.88
34 Resection of hepatocellular carcinoma without cirrhosis. Ann Surg 2012 0.87
35 Retracted Liver functional reserve estimation: state of the art and relevance to local treatments. Oncology 2010 0.86
36 Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 2008 0.86
37 Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdom Imaging 2011 0.86
38 Giant hemangioma of the adrenal. Isr Med Assoc J 2004 0.85
39 Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB (Oxford) 2013 0.84
40 Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors. J Clin Oncol 2013 0.84
41 Carcinoma ex microcystic adenoma of the pancreas: a report of a novel form of malignancy in serous neoplasms. Am J Surg Pathol 2012 0.83
42 Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation 2005 0.83
43 Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective. J Hepatobiliary Pancreat Sci 2009 0.83
44 Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal. Liver Transpl 2006 0.82
45 Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl 2005 0.82
46 The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer 2014 0.81
47 The role of fibrin sealants in hepatic surgery. Surg Technol Int 2007 0.81
48 Diaphragmatic hernia after hepatic resection: case series at a single Western institution. J Gastrointest Surg 2012 0.81
49 Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology 2015 0.79
50 Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor. Pancreas 2014 0.79
51 Clinical research in hepatocellular carcinoma: study design and endpoints. J Hepatol 2009 0.79
52 FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation. Clin Nucl Med 2007 0.79
53 Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experience. Hepatogastroenterology 2011 0.78
54 Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg 2003 0.78
55 Hepatocellular carcinoma in chronic hepatitis C in the absence of advanced fibrosis or cirrhosis. AJR Am J Roentgenol 2013 0.77
56 Multiple inflammatory and serum amyloid A positive telangiectatic hepatic adenomas with glycogenated nuclei arising in a background of nonalcoholic steatohepatitis. Semin Liver Dis 2008 0.77
57 Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford) 2012 0.77
58 Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013 0.77
59 A two-step right hepatic lobectomy with portal vein ligation for large hepatocellular carcinoma: rapid induction of left-lobe regeneration and clinicopathologic correlation. Semin Liver Dis 2013 0.76
60 Functional abdominal complaints occurred frequently in living liver donors after donation. Scand J Gastroenterol 2010 0.76
61 Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience. Int J Surg Oncol 2012 0.76
62 Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases. Pancreas 2016 0.75
63 Expansion of criteria for transplanting patients with hepatocellular carcinoma. Liver Transpl 2008 0.75
64 Reply:. Hepatology 2013 0.75
65 Recurrent giant hemangiomas of liver: Report of two rare cases with literature review. World J Gastrointest Surg 2012 0.75
66 Calcified telangiectatic hyperplastic nodule associated with vascular malformation in a child: a case report. Fetal Pediatr Pathol 2014 0.75
67 Renal artery thrombosis following secondary cytoreduction in a patient with ovarian cancer. Gynecol Oncol 2007 0.75
68 A 48-year-old obese man with a 3 cm liver lesion and a history of hemochromatosis and lymphoma. Semin Liver Dis 2004 0.75
69 Metzenbaum-assisted liver resection: a safe and effective liver resection technique. Dig Surg 2014 0.75